Titre : | The efficacy and short-term effects of electronic cigarettes as a method for smoking cessation: a systematic review and a meta-analysis (2016) |
Auteurs : | S. KHOUDIGIAN ; T. DEVJI ; L. LYTVYN ; K. CAMPBELL ; R. HOPKINS ; D. O’REILLY |
Type de document : | Article : Périodique |
Dans : | International Journal of Public Health (Vol.61, n°2, March 2016) |
Article en page(s) : | 257-267 |
Langues: | Anglais |
Discipline : | EPI (Epidémiologie / Epidemiology) |
Mots-clés : |
Thésaurus mots-clés ARRET DU TABAC ; E-CIGARETTE ; EFFICACITE ; SEVRAGE ; SUBSTITUTS NICOTINIQUES ; COMPARAISON ; TABAC ; SYNDROME DE SEVRAGE ; EFFET SECONDAIRE |
Résumé : |
Objectives: E-cigarettes are increasingly popular as smoking cessation aids. This review assessed the efficacy of e-cigarettes for smoking cessation as well as desire to smoke, withdrawal symptoms, and adverse events in adult smokers.
Methods: A systematic review was conducted. Studies comparing e-cigarettes to other nicotine replacement therapies or placebo were included. Data were pooled using meta-analysis. Results: Of 569 articles, 5 were eligible. Study participants were more likely to stop smoking when using nicotine e-cigarettes (43/489, 9%) versus placebo e-cigarettes (8/173, 5%); however, this difference was not statistically significant (RR 2.02; 95% CI 0.97, 4.22). The pooled effect estimates for the desire to smoke (RR -0.22; 95% CI -0.80, 0.36), irritability (RR -0.03; 95% CI -0.38, 0.31), restlessness (RR -0.03; 95% CI -0.42, 0.35), poor concentration (RR -0.01; 95% CI -0.35, 0.32), depression (RR -0.01; 95% CI -0.22, 0.20), hunger (RR -0.01; 95% CI -0.32, 0.30), and average number of non-serious adverse events (RR -0.09; 95% CI -0.28, 0.46) were not statistically significantly different. Only one study reported serious adverse events with no apparent association with e-cigarette use. Conclusions: Limited low-quality evidence of a non-statistically significant trend toward smoking cessation in adults using nicotine e-cigarettes exists compared with other therapies or placebo. Larger, high-quality studies are needed to inform policy decisions. |
Domaine : | Tabac / Tobacco / e-cigarette |
Sous-type de document : | Méta-analyse / Meta-analysis ; Revue de la littérature / Literature review |
Affiliation : | Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada |
Accueil